<table border="0" cellpadding="0" cellspacing="0" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<tbody>
<tr stylecode="Botrule">
<td align="left" stylecode="Lrule Rrule" valign="top"> <br/>
<content stylecode="bold">Interacting Drug</content>
<br/> <br/>
<br/>
</td>
<td align="left" stylecode="Rrule" valign="top"> <br/>
<content stylecode="bold">Interaction </content>
<br/> <br/>
<br/>
</td>
</tr>
<tr stylecode="Botrule">
<td align="left" stylecode="Lrule Rrule" valign="top"> <br/>Multivalent cation-containing products including antacids, metal cations or didanosine<br/> <br/>
<br/>
</td>
<td stylecode="Rrule" valign="top">Absorption of levofloxacin is decreased when the tablet or oral solution formulation is taken within 2 hours of these products.  Do not co-administer the intravenous formulation in the same IV line with a multivalent cation, e.g., magnesium (<linkhtml href="#c206af41-3469-4af1-90aa-f7273af5bb06">2.4,</linkhtml>
<linkhtml href="#ce47aa4e-3932-4c00-a0e6-b7881c58a663">7.1</linkhtml>)<br/>
<br/>
</td>
</tr>
<tr stylecode="Botrule">
<td align="left" stylecode="Lrule Rrule" valign="top"> <br/>Warfarin<br/> <br/>
<br/>
</td>
<td stylecode="Rrule" valign="top">Effect may be enhanced. Monitor prothrombin time, INR, watch for bleeding (<linkhtml href="#ce30aac2-f4b6-4545-bf82-952bd67c854f">7.2</linkhtml>)<br/>
<br/>
</td>
</tr>
<tr>
<td align="left" stylecode="Lrule Rrule" valign="top"> <br/>Anti-diabetic agents<br/> <br/>
<br/>
</td>
<td stylecode="Rrule" valign="top">Carefully monitor blood glucose (<linkhtml href="#dee6ba83-e8e6-425b-bc40-08a057f5d701">5.11</linkhtml>, <linkhtml href="#d044d478-63f0-43b2-92f6-5b25f5836d75">7.3</linkhtml>)<br/>
<br/>
</td>
</tr>
</tbody>
</table>